Staar Surgical Company (STAA) 15.57 $STAA
STAAR Surgical To Present At Two Upcoming Investor Conferences
PR Newswire - Thu May 01, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management expects to participate in the following investor conferences:
Global Contact Lens (Gas Permeable Contact Lens and Soft Contact Lens) Market 2013 - 2019
M2 - Wed Apr 30, 6:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l56mzp/contact_lens) has announced the addition of the "Global Contact Lens (Gas Permeable Contact Lens and Soft Contact Lens) Market 2013 - 2019" report to their offering. Rising incidence of ophthalmic disorders, changing life style and increasing geriatric population are the major driving factors for the contact lens market. According to the National Eye Institute, there are more than 11 million Americans suffering from the common vision problems such as myopia, astigmatism and hyperopia every year. However, long-term use of these lenses may increase the chance of various vision problems such as cornea scratches, redness of eyes or blindness that is anticipated to hamper the growth of contact lens market during the forecast period of 2013 to 2019. Some of the major key players in this market are Johnson & Johnson, Essilor International, CooperVision, CIBA Vision, Hoya Corporation and others. The global market for contact lens was valued at USD 6,810.9 million in 2012 growing at a CAGR of 10.3% from 2013 to 2019. Contact lens market can be segmented on the basis of usage pattern into corrective lenses, therapeutic contact lenses, post-operative lenses, cosmetic lenses, enhancement tints, opaque and special effect contact lenses, prosthetic contact lenses, computer lenses, D-segment contact lenses, sports lenses and custom made lenses. Corrective lenses have the concave effects that enables images to refocus onto the retina, causing more precise refraction or focus. The corrective contact lens market accounted for the largest market segment in 2012 growing at a CAGR of 12.2% during the forecast period of 2013 to 2019. On the basis of design, the contact lens market is segmented into spherical, toric, multifocal and orthokeratology contact lens. Among these lenses, multifocal contact lens was valued at USD 553.7 million in 2012 and estimated as the fastest growing segment during the forecast period. These lenses contains two or more focal powers at different distances and can be used in correcting myopia. According to the American Academy of Ophthalmology, more than 32 million Americans suffer from myopia. With increasing incidence of this ophthalmic disorder, there will be an increase in uptake of multifocal contact lenses. Scope of the Report Characteristics - Gas-Permeable Contact Lens - Soft Contact Lens -- Daily Disposable -- Weekly Replacement -- Monthly Replacement -- Extended Wear -- Annual Replacement -- Unplanned Replacement Schedule Design - Spherical Contact Lens - Toric Contact Lens - Multifocal Contact Lens - Orthokeratology Contact Lens Usage - Corrective Contact Lens - Therapeutic Contact Lens - Post-Operative Therapeutic Contact Lens - Cosmetic Contact Lens - Enhancement Tints - Opaque and Special Effect Contact Lens - Prosthetic Contact Lens - Computer Lens - D-Segment Contact Lens - Sports Lens - Custom-made Contact Lens Companies Mentioned - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/l5...ntact_lens
STAAR Surgical Reports 12% First Quarter 2014 Revenue Growth
PR Newswire - Mon Apr 28, 3:01PM CDT
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye today reported revenue for the first quarter ended April 4, 2014 of $20.2 million, a 12% increase over $18.0 million reported for the first quarter of 2013. On a constant currency basis, revenues grew 15% during the first quarter of 2014 compared to the first quarter of 2013. The effect of foreign currency exchange reduced sales by $0.6 million during the quarter. The results included record quarterly sales of $12.2 million of the Company's Visian ICL product portfolio, and $6.6 million of its IOL products. Lower margin Other Product sales were $1.3 million, a 29% increase compared to the first quarter of 2013.
STAAR Surgical to Host Investor Breakfast and Webcast during the ASCRS Symposium on Cataract and Refractive Surgery
PR Newswire - Wed Apr 23, 5:01AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it is hosting an investor breakfast and webcast on Saturday, April 26 during the ASCRS Symposium on cataract and refractive surgery in Boston, MA.
Ophthalmology Diagnostics and Surgical Devices Market 2013-2019
M2 - Tue Apr 22, 8:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wttlds/ophthalmology) has announced the addition of the "Ophthalmology Diagnostics and Surgical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The ophthalmology industry is witnessing a rapid pace of technological advances in order to achieve efficient diagnosis and treatment platforms. Maintenance of normal vision is vital as eyes are one of the most crucial sensory organs. Defects in vision and other infections, inflammations may result in complete loss vision. Hence, various ophthalmological diagnostic and surgical treatment devices play an utmost important role so as to avoid vision loss and improve the quality of life of patients. The ophthalmic diagnostic platforms aid the ophthalmologist to have a detailed view of the internal eye structure and helps in examination of the microvasculature of the eye. Thus, providing appropriate diagnosis of the ophthalmic condition. Post diagnosis the patients are either prescribed vision care products in case of normal vision corrections (refractive errors) or surgeries are performed based on ophthalmic condition. Ophthalmology devices market can be analyzed by product type, applications and geography. The product type is further segmented into several diagnostic, surgery devices and vision care products. Vision care segment accounted for the largest market segment and was valued at USD 17,615.8 million in 2012 growing at CAGR of 7.1% throughout the forecast period from 2013 to 2019. This growth has been attributed towards the growth of large consumer base, rise in the number of advanced software applications along with increase in the incidence of ophthalmic refractive errors. As per the data published by World Health organization (WHO) in the year 2013, around 82% of the people aged 50 and above are currently living with blindness. Also, it had stated that uncorrected refractive errors have led to visual impairments especially in the low and middle income economies. Innovation and novelty in several diagnostic platforms such as the use of mobile smart phone applications for eye visualization and hand held instruments has boosted the growth and uptake of several diagnostic platforms. Also with the extensive use of lasers such as femtosecond, excimer and YAG (yttrium aluminum garnet) lasers, ophthalmology surgery devices market is now exhibiting a tremendous growth potential. Moreover, with the use of LASIK (Laser-Assisted in Situ Keratomileusis) surgery techniques, Vitreoretinal techniques, Intra ocular lenses (IOLs) and retinal implants are anticipated to push the growth of surgical equipment market. The applications market of ophthalmology devices represents the diagnosis, surgery and vision care. The diagnostic and surgical applications are interdependent to a certain extent. Post diagnosis of the ophthalmological condition, the mode of treatment is decided. Scope Product Type Diagnostic Devices - Autorefractometers - Slit lamps - Tonometers - Ophthalmoscopes - Fundus Cameras - Fluorescein Angiography - Optical coherence Tomography (OCT) Systems - Ophthalmic Echography (Ultrasound) - Keratometers - Gonioscopes - Pachymeters - Perimeters - Corneal Topographers - Specular Microscopes Ophthalmology Surgery Devices - Cataract Surgery Devices - Refractive Surgery Devices - Glaucoma Surgery Devices - Vitreoretinal Surgery Devices Vision Care - Contact Lenses - Spectacle Lenses Applications - Diagnostics - Surgical - Vision Care Key Topics Covered: - Introduction - Executive Summary - Market Overview - Global ophthalmology Devices Market, by Product Type - Global Ophthalmology diagnostics and Surgical Devices Market, by Application - Global Ophthalmology Diagnostics and Surgical Devices Market, by Geography - Recommendations - Company Profiles - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb, Inc. (Valeant Pharmaceuticals) - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/wt...thalmology
Nasdaq stocks posting largest percentage increases
AP - Mon Apr 21, 12:20PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
STAAR Surgical Announces First Quarter 2014 Results Release Date, Conference Call and Webcast
PR Newswire - Thu Apr 17, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the first quarter ended April 4, 2014 on Monday, April 28, 2014 after the market close.
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Ventura County Eye Surgeon Helps Persuade FDA Panel to Support Approval of Long-Awaited Lens Implant
Marketwire - Tue Mar 25, 10:05AM CDT
Ophthalmic surgeon and researcher Dr. Paul Dougherty presented evidence and opinion at the U.S. Food and Drug Administration (FDA) Medical Devices Advisory Committee hearing May 14th that helped persuade the committee to vote in favor of STAAR Surgical's Visian(R) Toric Implantable Collamer(R) Lens (TICL(TM)) -- the first-of-its-kind in the U.S. lens implant designed to treat both nearsightedness and astigmatism in a single procedure.
4 Unusual-Volume Stocks in Breakout Territory
at The Street - Tue Mar 25, 5:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Upgrade Alert for STAAR Surgical (STAA)
Comtex SmarTrend(R) - Mon Mar 24, 7:04AM CDT
STAAR Surgical (NASDAQ:STAA) was upgraded from Market Perform to Outperform at William Blair today. The stock closed yesterday at $16.61 on volume of 334,000 shares, above average daily volume of 296,000. STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
STAAR Surgical Company (STAA) Soars: Stock Up 15.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 8:39AM CDT
STAAR Surgical Company was a big mover last session, as its shares rose over 15% on the day.
Why STAAR Surgical Company Shares Are Seeing Big Gains
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 17, 1:03PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of STAAR Surgical , a developer of...
FDA Advisory Panel Votes in Favor of STAAR Surgical's Visian® Toric Implantable Collamer® Lens, TICL(TM)
PR Newswire - Mon Mar 17, 5:01AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration's (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes recommendations to the Commissioner of Food and Drugs.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
STAAR Surgical To Present At Two Upcoming Investor Conferences
PR Newswire - Thu May 01, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management expects to participate in the following investor conferences:
Global Contact Lens (Gas Permeable Contact Lens and Soft Contact Lens) Market 2013 - 2019
M2 - Wed Apr 30, 6:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l56mzp/contact_lens) has announced the addition of the "Global Contact Lens (Gas Permeable Contact Lens and Soft Contact Lens) Market 2013 - 2019" report to their offering. Rising incidence of ophthalmic disorders, changing life style and increasing geriatric population are the major driving factors for the contact lens market. According to the National Eye Institute, there are more than 11 million Americans suffering from the common vision problems such as myopia, astigmatism and hyperopia every year. However, long-term use of these lenses may increase the chance of various vision problems such as cornea scratches, redness of eyes or blindness that is anticipated to hamper the growth of contact lens market during the forecast period of 2013 to 2019. Some of the major key players in this market are Johnson & Johnson, Essilor International, CooperVision, CIBA Vision, Hoya Corporation and others. The global market for contact lens was valued at USD 6,810.9 million in 2012 growing at a CAGR of 10.3% from 2013 to 2019. Contact lens market can be segmented on the basis of usage pattern into corrective lenses, therapeutic contact lenses, post-operative lenses, cosmetic lenses, enhancement tints, opaque and special effect contact lenses, prosthetic contact lenses, computer lenses, D-segment contact lenses, sports lenses and custom made lenses. Corrective lenses have the concave effects that enables images to refocus onto the retina, causing more precise refraction or focus. The corrective contact lens market accounted for the largest market segment in 2012 growing at a CAGR of 12.2% during the forecast period of 2013 to 2019. On the basis of design, the contact lens market is segmented into spherical, toric, multifocal and orthokeratology contact lens. Among these lenses, multifocal contact lens was valued at USD 553.7 million in 2012 and estimated as the fastest growing segment during the forecast period. These lenses contains two or more focal powers at different distances and can be used in correcting myopia. According to the American Academy of Ophthalmology, more than 32 million Americans suffer from myopia. With increasing incidence of this ophthalmic disorder, there will be an increase in uptake of multifocal contact lenses. Scope of the Report Characteristics - Gas-Permeable Contact Lens - Soft Contact Lens -- Daily Disposable -- Weekly Replacement -- Monthly Replacement -- Extended Wear -- Annual Replacement -- Unplanned Replacement Schedule Design - Spherical Contact Lens - Toric Contact Lens - Multifocal Contact Lens - Orthokeratology Contact Lens Usage - Corrective Contact Lens - Therapeutic Contact Lens - Post-Operative Therapeutic Contact Lens - Cosmetic Contact Lens - Enhancement Tints - Opaque and Special Effect Contact Lens - Prosthetic Contact Lens - Computer Lens - D-Segment Contact Lens - Sports Lens - Custom-made Contact Lens Companies Mentioned - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/l5...ntact_lens
STAAR Surgical Reports 12% First Quarter 2014 Revenue Growth
PR Newswire - Mon Apr 28, 3:01PM CDT
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye today reported revenue for the first quarter ended April 4, 2014 of $20.2 million, a 12% increase over $18.0 million reported for the first quarter of 2013. On a constant currency basis, revenues grew 15% during the first quarter of 2014 compared to the first quarter of 2013. The effect of foreign currency exchange reduced sales by $0.6 million during the quarter. The results included record quarterly sales of $12.2 million of the Company's Visian ICL product portfolio, and $6.6 million of its IOL products. Lower margin Other Product sales were $1.3 million, a 29% increase compared to the first quarter of 2013.
STAAR Surgical to Host Investor Breakfast and Webcast during the ASCRS Symposium on Cataract and Refractive Surgery
PR Newswire - Wed Apr 23, 5:01AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it is hosting an investor breakfast and webcast on Saturday, April 26 during the ASCRS Symposium on cataract and refractive surgery in Boston, MA.
Ophthalmology Diagnostics and Surgical Devices Market 2013-2019
M2 - Tue Apr 22, 8:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wttlds/ophthalmology) has announced the addition of the "Ophthalmology Diagnostics and Surgical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The ophthalmology industry is witnessing a rapid pace of technological advances in order to achieve efficient diagnosis and treatment platforms. Maintenance of normal vision is vital as eyes are one of the most crucial sensory organs. Defects in vision and other infections, inflammations may result in complete loss vision. Hence, various ophthalmological diagnostic and surgical treatment devices play an utmost important role so as to avoid vision loss and improve the quality of life of patients. The ophthalmic diagnostic platforms aid the ophthalmologist to have a detailed view of the internal eye structure and helps in examination of the microvasculature of the eye. Thus, providing appropriate diagnosis of the ophthalmic condition. Post diagnosis the patients are either prescribed vision care products in case of normal vision corrections (refractive errors) or surgeries are performed based on ophthalmic condition. Ophthalmology devices market can be analyzed by product type, applications and geography. The product type is further segmented into several diagnostic, surgery devices and vision care products. Vision care segment accounted for the largest market segment and was valued at USD 17,615.8 million in 2012 growing at CAGR of 7.1% throughout the forecast period from 2013 to 2019. This growth has been attributed towards the growth of large consumer base, rise in the number of advanced software applications along with increase in the incidence of ophthalmic refractive errors. As per the data published by World Health organization (WHO) in the year 2013, around 82% of the people aged 50 and above are currently living with blindness. Also, it had stated that uncorrected refractive errors have led to visual impairments especially in the low and middle income economies. Innovation and novelty in several diagnostic platforms such as the use of mobile smart phone applications for eye visualization and hand held instruments has boosted the growth and uptake of several diagnostic platforms. Also with the extensive use of lasers such as femtosecond, excimer and YAG (yttrium aluminum garnet) lasers, ophthalmology surgery devices market is now exhibiting a tremendous growth potential. Moreover, with the use of LASIK (Laser-Assisted in Situ Keratomileusis) surgery techniques, Vitreoretinal techniques, Intra ocular lenses (IOLs) and retinal implants are anticipated to push the growth of surgical equipment market. The applications market of ophthalmology devices represents the diagnosis, surgery and vision care. The diagnostic and surgical applications are interdependent to a certain extent. Post diagnosis of the ophthalmological condition, the mode of treatment is decided. Scope Product Type Diagnostic Devices - Autorefractometers - Slit lamps - Tonometers - Ophthalmoscopes - Fundus Cameras - Fluorescein Angiography - Optical coherence Tomography (OCT) Systems - Ophthalmic Echography (Ultrasound) - Keratometers - Gonioscopes - Pachymeters - Perimeters - Corneal Topographers - Specular Microscopes Ophthalmology Surgery Devices - Cataract Surgery Devices - Refractive Surgery Devices - Glaucoma Surgery Devices - Vitreoretinal Surgery Devices Vision Care - Contact Lenses - Spectacle Lenses Applications - Diagnostics - Surgical - Vision Care Key Topics Covered: - Introduction - Executive Summary - Market Overview - Global ophthalmology Devices Market, by Product Type - Global Ophthalmology diagnostics and Surgical Devices Market, by Application - Global Ophthalmology Diagnostics and Surgical Devices Market, by Geography - Recommendations - Company Profiles - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb, Inc. (Valeant Pharmaceuticals) - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/wt...thalmology
Nasdaq stocks posting largest percentage increases
AP - Mon Apr 21, 12:20PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
STAAR Surgical Announces First Quarter 2014 Results Release Date, Conference Call and Webcast
PR Newswire - Thu Apr 17, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the first quarter ended April 4, 2014 on Monday, April 28, 2014 after the market close.
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Ventura County Eye Surgeon Helps Persuade FDA Panel to Support Approval of Long-Awaited Lens Implant
Marketwire - Tue Mar 25, 10:05AM CDT
Ophthalmic surgeon and researcher Dr. Paul Dougherty presented evidence and opinion at the U.S. Food and Drug Administration (FDA) Medical Devices Advisory Committee hearing May 14th that helped persuade the committee to vote in favor of STAAR Surgical's Visian(R) Toric Implantable Collamer(R) Lens (TICL(TM)) -- the first-of-its-kind in the U.S. lens implant designed to treat both nearsightedness and astigmatism in a single procedure.
4 Unusual-Volume Stocks in Breakout Territory
at The Street - Tue Mar 25, 5:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Upgrade Alert for STAAR Surgical (STAA)
Comtex SmarTrend(R) - Mon Mar 24, 7:04AM CDT
STAAR Surgical (NASDAQ:STAA) was upgraded from Market Perform to Outperform at William Blair today. The stock closed yesterday at $16.61 on volume of 334,000 shares, above average daily volume of 296,000. STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
STAAR Surgical Company (STAA) Soars: Stock Up 15.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 8:39AM CDT
STAAR Surgical Company was a big mover last session, as its shares rose over 15% on the day.
Why STAAR Surgical Company Shares Are Seeing Big Gains
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 17, 1:03PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of STAAR Surgical , a developer of...
FDA Advisory Panel Votes in Favor of STAAR Surgical's Visian® Toric Implantable Collamer® Lens, TICL(TM)
PR Newswire - Mon Mar 17, 5:01AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration's (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes recommendations to the Commissioner of Food and Drugs.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
